Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment
Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinso...
Last updated: 2026-02-21 21:34:39 ET
Pulse AI Brief
Updated Feb 21, 2026 8:00 PM ET
Greenlight Capital's CEO has urged investors to protect their portfolios against a potential decline in the U.S. dollar. The advice comes amid growing concerns about inflation and fiscal policy impacts on currency stability.
Investors may shift towards commodities, foreign currencies, and other hedges, potentially impacting forex markets and commodity prices. This sentiment reflects broader market caution regarding U.S. monetary policy.
The warning highlights ongoing debates about the sustainability of current fiscal policies and their long-term effects on the U.S. economy and global financial stability.
Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinso...